FindTrial
Sign In

Pharmacogenetic of propofol

Pharmacogenetic of propofol

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001309-40-SE
Enrollment
Unknown
Registered
2008-03-18
Start date
2008-06-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition or disease are investigated. This study will investigated the polymorfism in genes that are involved in the metabolism of a anastetic agent-propofol.

Interventions

Trade Name: Propofol Pharmaceutical Form: Intravenous infusion INN or Proposed INN: PROPOFOL CAS Number: 2078548 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentrati

Sponsors

Linköping university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ASA 1,healthy,caucasian patient undergoing surgery more that 30 min. Elective surgery Age 18-50 years BMI 20-30 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Pregnacy Acute surgery Smokers allergic to nuts allergic to propofol misuse of alcohol not caucasian

Design outcomes

Primary

MeasureTime frame
Main Objective: To study the polymorfism of genes for the metabolism of propofol;Secondary Objective: ;Primary end point(s): There are no endpoint in this study. Please read the protocol:—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026